Skip to main content
. 2016 Jan 20;11(3):235–247. doi: 10.2217/nnm.15.193

Figure 4. . Cell viability of MDA-MB-231 cells after treatment for 48 h with varying concentrations (0–3 μg/ml) of doxorubicin alone, in conjunction with 1.25 μM free orlistat and in conjunction with 1.25 μM orlistat-loaded PLGA-PEG nanoparticles as assessed by propidium iodide-staining-based FACS analysis.

Figure 4. 

Shown here is (A) the graph for cell viability for the range of concentrations of doxorubicin and (B) dose–response for each of the three conditions.

NP: Nanoparticle.